Lung Cancer Supportive Care Protocol

Lung cancer is a serious condition that requires comprehensive medical treatment including surgery, chemotherapy, radiation, targeted therapy, and/or immunotherapy depending on the type and stage. While no supplement can cure cancer, certain supplements may help support quality of life, manage treatment side effects, and maintain nutritional status during this challenging time.

CRITICAL: This protocol is for SUPPORTIVE CARE only, not cancer treatment. ALWAYS discuss supplements with your oncology team before starting—some may interact with chemotherapy, radiation, or targeted therapies. Never delay or replace conventional cancer treatment with supplements.

•Omega-3 Fatty Acids have strong anti-inflammatory effects and may help combat cancer cachexia (the muscle wasting and weight loss common in lung cancer). Studies show omega-3 supplementation can help maintain lean body mass, improve appetite, and enhance quality of life during treatment.

•Vitamin D deficiency is very common in lung cancer patients and is associated with worse outcomes. While it's not clear if supplementation improves outcomes, maintaining adequate vitamin D levels supports immune function and bone health (important given increased osteoporosis risk).

•Melatonin has been studied as an adjunctive therapy in cancer. Beyond improving sleep (often disrupted in cancer patients), melatonin has antioxidant and possibly anticancer effects. Some studies suggest it may improve quality of life and potentially treatment response, though more research is needed.

•Glutamine is an amino acid that supports rapidly dividing cells, including those lining the gut. It may help reduce chemotherapy-induced mucositis (mouth sores) and peripheral neuropathy (numbness/tingling in hands and feet). It's one of the better-studied supportive supplements in oncology.

•Ginger can help with chemotherapy-induced nausea and vomiting (CINV). It works through multiple mechanisms and can be used alongside standard anti-nausea medications. Taking it before chemotherapy sessions may be most effective.

•Astragalus is a traditional Chinese medicine herb used for centuries to support immunity. Studies, primarily from China, suggest it may help reduce chemotherapy side effects and support immune function during treatment.

•CoQ10 is an antioxidant that may help protect the heart from chemotherapy-induced cardiotoxicity. This is particularly relevant for patients receiving certain chemotherapy agents known to affect the heart.

•Medicinal Mushrooms like Turkey Tail (Coriolus versicolor) contain polysaccharides (PSK, PSP) that have been studied as adjuvant cancer therapy, particularly in Asia. They may support immune function during treatment.

Expected timeline: These supplements provide ongoing support during and after treatment. Effects on quality of life may be noticed within 2-4 weeks. Always coordinate timing with your cancer treatment schedule.

Clinical Perspective

Lung cancer includes non-small cell lung cancer (NSCLC, ~85%) and small cell lung cancer (SCLC, ~15%). Treatment depends on type, stage, molecular markers (EGFR, ALK, PD-L1, etc.), and patient factors. May include surgery, chemotherapy, radiation, targeted therapy (TKIs for EGFR/ALK+), immunotherapy (checkpoint inhibitors). Common issues: cachexia, fatigue, nausea, peripheral neuropathy, mucositis, immune suppression. Integrative oncology focuses on symptom management, quality of life, and minimizing treatment toxicity.

CRITICAL: Supplements must be discussed with oncology team. Many have potential interactions: antioxidants may theoretically reduce chemotherapy/radiation efficacy (debated, timing-dependent). Some supplements affect drug metabolism (CYP450). Immunomodulators may interact with immunotherapy. Bleeding risk with surgery. Never replace standard treatment.

•Omega-3 Fatty Acids (B-grade): EPA/DHA reduce inflammation (↓IL-6, TNF-α, CRP), may attenuate muscle protein breakdown in cachexia. Systematic review: EPA-enriched supplements improve weight and lean body mass in cancer cachexia (PMID: 29568839). RCT in NSCLC: fish oil improved weight maintenance during chemotherapy (PMID: 24912935). 2-4g EPA+DHA daily. Generally safe; minor anticoagulant effect—hold before surgery.

•Vitamin D (B-grade): VDR widely expressed; vitamin D affects cell proliferation, apoptosis, angiogenesis. Deficiency in 70-90% of lung cancer patients. Meta-analysis: higher circulating vitamin D associated with better lung cancer survival (PMID: 25252963). Supplementation to correct deficiency recommended; target 40-60 ng/mL. 2000-4000 IU daily; check baseline and monitor.

•Melatonin (B-grade): Antioxidant, immunomodulator, circadian regulator. Possible direct anticancer effects (antiproliferative, pro-apoptotic). Systematic review: high-dose melatonin (20mg) as adjunct to chemotherapy improved tumor response and survival in several cancers (PMID: 15687434). Meta-analysis in solid tumors: improved 1-year survival, reduced chemotherapy side effects (PMID: 25415541). 10-20mg nightly. Well-tolerated. Discuss with oncologist.

•Glutamine (B-grade): Conditionally essential amino acid; fuel for enterocytes and immune cells. Depleted during chemotherapy. Meta-analysis: oral glutamine reduces severity and duration of chemotherapy-induced mucositis (PMID: 26784918). Also studied for peripheral neuropathy prevention. 10-30g daily in divided doses during chemotherapy. Generally safe.

•Ginger (B-grade): Contains gingerols/shogaols with anti-emetic effects via 5-HT3 receptor antagonism, gastric motility. Systematic review: ginger as adjunct reduces chemotherapy-induced nausea and vomiting (PMID: 22430619). 1-2g daily, starting before chemotherapy. Use with standard antiemetics, not as replacement.

•Astragalus (C-grade): Contains astragalosides with immunomodulatory effects (↑IL-2, IFN-γ, NK cell activity). Used in Traditional Chinese Medicine. Systematic review: astragalus-based formulas combined with platinum-based chemotherapy improved tumor response and reduced side effects in NSCLC (PMID: 26185985). Evidence mostly from Chinese studies. 500-1000mg standardized extract. May stimulate immune system—caution with immunotherapy.

•CoQ10 (C-grade): Mitochondrial antioxidant; may protect cardiomyocytes from anthracycline toxicity. Review: CoQ10 may reduce cardiotoxicity risk (PMID: 20930102). Limited lung cancer-specific data. 100-300mg daily. Theoretical concern about reducing chemotherapy efficacy not supported by clinical data.

•Medicinal Mushrooms / Coriolus versicolor (C-grade): PSK (polysaccharide-K) and PSP are protein-bound polysaccharides that activate NK cells, macrophages, dendritic cells; may enhance Th1 response. Systematic review: used adjuvantly in Japan/China; may improve immune function and quality of life (PMID: 22972060). 1-3g PSK/PSP daily. Generally well-tolerated.

Biomarker targets: Nutritional status (weight, albumin, prealbumin), inflammatory markers (CRP, IL-6), vitamin D levels, quality of life assessments (FACT-L, EORTC QLQ-LC13), treatment response markers, blood counts (bone marrow function).

Protocol notes: Coordinate all supplements with oncology team. Timing of antioxidants debated—some advise avoiding around chemotherapy/radiation (theoretical efficacy reduction); others suggest timing away from treatment. Hold supplements with anticoagulant effects before surgery. Adequate protein intake (1.2-1.5 g/kg) for muscle maintenance. Consider nutrition consultation. Address pain, fatigue, dyspnea per palliative care principles. Smoking cessation essential even after diagnosis. Psychosocial support critical. Screen for depression. Support groups beneficial. Advance care planning. Physical activity as tolerated improves outcomes. Pulmonary rehabilitation may help. Integrative approaches (acupuncture, massage, mind-body practices) can complement conventional care.

View All Protocols